Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)

被引:342
作者
Degos, Francoise [1 ]
Perez, Paul [2 ,7 ]
Roche, Bruno [3 ]
Mahmoudi, Amel [4 ]
Asselineau, Julien [2 ,7 ]
Voitot, Helene [5 ]
Bedossa, Pierre [6 ]
机构
[1] Hop Beaujon, Hepatol Dept, APHP, INSERM,U773, F-92110 Clichy, France
[2] CHU Bordeaux, Clin Epidemiol Unit, Bordeaux, France
[3] Hop Paul Brousse, APHP, INSERM Paris Sud, CHB,U785, Villejuif, France
[4] Hop Jean Verdier, APHP, Bondy, France
[5] Hop Beaujon, Dept Biochem, APHP, Clichy, France
[6] Hop Beaujon, INSERM, APHP, Dept Pathol,U773, Clichy, France
[7] CIC EC7, Bordeaux, France
关键词
Liver fibrosis non invasive tests; Chronic hepatitis B; Chronic hepatitis; C Liver biopsy; TRANSIENT ELASTOGRAPHY; CIRRHOSIS; BIOPSY; STIFFNESS;
D O I
10.1016/j.jhep.2010.05.035
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims The diagnostic accuracy of non-invasive liver fibrosis tests that may replace liver biopsy in patients with chronic hepatitis remains controversial We assessed and compared the accuracy of FibroScan (R) and that of the main biomarkers used for predicting cirrhosis and significant fibrosis (METAVIR >= F2) in patients with chronic viral hepatitis Methods A multicenter prospective cross-sectional diagnostic accuracy study was conducted in the Hepatology departments of 23 French university hospitals Index tests and reference standard (METAVIR fibrosis score on liver biopsy) were measured on the same day and interpreted blindly Consecutive patients with chronic viral hepatitis (hepatitis B or C virus including possible Human Immunodeficiency Virus co-infection) requiring liver biopsy were recruited in the study Results The analysis was first conducted on the total population (1839 patients) and after excluding 532 protocol deviations on 1307 patients (non-compliant FibroScan examinations) The overall accuracy of FibroScan was high (AUROC 089 and 090 respectively) and significantly higher than that of biomarkers in predicting cirrhosis (AUROC 0 77-0 86) All non-invasive methods had a moderate accuracy in predicting significant fibrosis (AUROC 0 72-0 78) Based on multilevel likelihood ratios non-invasive tests provided a relevant gain in the likelihood of diagnosis in 0-60% of patients (cirrhosis) and 9-30% of patients (significant fibrosis) Conclusions The diagnostic accuracy of non-invasive tests was high for cirrhosis but poor for significant fibrosis A clinically relevant gain in the likelihood of diagnosis was achieved in a low proportion of patients Although the diagnosis of cirrhosis may rely on non-invasive tests liver biopsy is warranted to diagnose intermediate stages of fibrosis (C) 2010 European Association for the Study of the Liver Published by Elsevier B V All rights reserved
引用
收藏
页码:1013 / 1021
页数:9
相关论文
共 33 条
[1]   Hepascore: An accurate validated predictor of liver fibrosis in chronic hepatitis C infection [J].
Adams, LA ;
Bulsara, M ;
Rossi, E ;
Deboer, B ;
Speers, D ;
George, J ;
Kench, J ;
Farrell, G ;
McCaughan, GW ;
Jeffrey, GP .
CLINICAL CHEMISTRY, 2005, 51 (10) :1867-1873
[2]  
[Anonymous], 2007, HLTH TECHNOL ASSESS
[3]   Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C [J].
Arena, U. ;
Vizzutti, F. ;
Abraldes, J. G. ;
Corti, G. ;
Stasi, C. ;
Moscarella, S. ;
Milani, S. ;
Lorefice, E. ;
Petrarca, A. ;
Romanelli, R. G. ;
Laffi, G. ;
Bosch, J. ;
Marra, F. ;
Pinzani, M. .
GUT, 2008, 57 (09) :1288-1293
[4]  
Bedossa P, 2003, HEPATOLOGY, V38, p337A
[5]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[6]   Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Lijmer, JG ;
Moher, D ;
Rennie, D ;
de Vet, HCW .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (01) :40-44
[7]   Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C [J].
Boursier, Jerome ;
Bacq, Yannick ;
Halfon, Philippe ;
Leroy, Vincent ;
de Ledinghen, Victor ;
de Muret, Anne ;
Bourliere, Marc ;
Sturm, Nathalie ;
Foucher, Juliette ;
Oberti, Frederic ;
Rousselet, Marie Christine ;
Cales, Paul .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (01) :28-38
[8]   Practices of liver biopsy in France: Results of a prospective nationwide survey [J].
Cadranel, JF ;
Rufat, P ;
Degos, F .
HEPATOLOGY, 2000, 32 (03) :477-481
[9]   Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C [J].
Castéra, L ;
Vergniol, J ;
Foucher, J ;
Le Bail, B ;
Chanteloup, E ;
Haaser, M ;
Darriet, M ;
Couzigou, P ;
De Lédinghen, V .
GASTROENTEROLOGY, 2005, 128 (02) :343-350
[10]   Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations [J].
Castera, Laurent ;
Foucher, Juliette ;
Bernard, Pierre-Henri ;
Carvalho, Francoise ;
Allaix, Daniele ;
Merrouche, Wassil ;
Couzigou, Patrice ;
de Ledinghen, Victor .
HEPATOLOGY, 2010, 51 (03) :828-835